Scarica l'app Stockscreener
36.59
1.82%
0.655
Dopo l'orario di chiusura:
35.87
-0.725
-1.98%
Precedente Chiudi:
$35.94
Aprire:
$36.29
Volume 24 ore:
104.06K
Relative Volume:
0.84
Capitalizzazione di mercato:
$530.09M
Reddito:
$1.80M
Utile/perdita netta:
$1.76B
Rapporto P/E:
0.3084
EPS:
118.674
Flusso di cassa netto:
$-149.23M
1 W Prestazione:
+4.56%
1M Prestazione:
+37.73%
6M Prestazione:
+219.05%
1 anno Prestazione:
+128.01%
Intervallo 1D:
$34.77
$37.25
Intervallo di 1 settimana:
$31.28
$37.25
Portata 52W:
$10.80
$37.53
Inhibrx Biosciences Inc Stock (INBX) Company Profile
Nome
Inhibrx Biosciences Inc
Settore
Industria
Telefono
(858) 795-4220
Indirizzo
11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA
Confronta INBX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INBX
Inhibrx Biosciences Inc
|
36.59 | 504.24M | 1.80M | 1.76B | -149.23M | 118.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Inhibrx Biosciences Inc Stock (INBX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-23 | Iniziato | JMP Securities | Mkt Perform |
| 2024-01-23 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-03-16 | Iniziato | SMBC Nikko | Outperform |
| 2021-09-21 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2020-09-14 | Iniziato | Credit Suisse | Outperform |
| 2020-09-14 | Iniziato | Evercore ISI | Outperform |
Mostra tutto
Inhibrx Biosciences Inc Borsa (INBX) Ultime notizie
What does recent volatility data suggest for Inhibrx Biosciences Inc.Market Activity Summary & Daily Entry Point Trade Alerts - newser.com
Why Inhibrx Biosciences Inc. stock appeals to analystsEarnings Overview Summary & Fast Exit and Entry Trade Guides - newser.com
How hedge fund analytics apply to Inhibrx Biosciences Inc. stockJuly 2025 Fed Impact & High Conviction Investment Ideas - newser.com
Can Inhibrx Biosciences Inc. stock beat analyst upgradesInsider Selling & Accurate Buy Signal Alerts - newser.com
How to recover losses in Inhibrx Biosciences Inc. stock2025 Trading Recap & Risk Controlled Swing Alerts - newser.com
Regression analysis insights on Inhibrx Biosciences Inc. performanceCPI Data & Accurate Technical Buy Alerts - newser.com
Using economic indicators to assess Inhibrx Biosciences Inc. potentialJuly 2025 Catalysts & Entry and Exit Point Strategies - newser.com
Will Inhibrx Biosciences Inc. benefit from macro trendsMarket Performance Summary & Verified Chart Pattern Trade Signals - newser.com
Published on: 2025-10-13 10:37:41 - newser.com
What to expect from Inhibrx Biosciences Inc. in the next 30 days2025 Major Catalysts & Community Verified Swing Trade Signals - newser.com
Owning 45% shares,institutional owners seem interested in Inhibrx Biosciences, Inc. (NASDAQ:INBX), - Yahoo Finance
Insider Selling: Inhibrx Biosciences (NASDAQ:INBX) Major Shareholder Sells 350,000 Shares of Stock - MarketBeat
Automated trading signals detected on Inhibrx Biosciences Inc.Weekly Trend Summary & High Return Trade Opportunity Guides - newser.com
Market reaction to Inhibrx Biosciences Inc.’s recent newsOil Prices & Growth Focused Stock Reports - newser.com
Inhibrx Biosciences Inc. recovery potential after sell offWeekly Profit Analysis & Reliable Volume Spike Alerts - newser.com
How to interpret RSI for Inhibrx Biosciences Inc. stock2025 Investor Takeaways & AI Enhanced Trading Signals - newser.com
Can Inhibrx Biosciences Inc. stock resist market sell offs2025 Performance Recap & Community Trade Idea Sharing - newser.com
Intraday pattern recognizer results for Inhibrx Biosciences Inc.2025 Dividend Review & Real-Time Market Trend Scan - newser.com
Is now a turning point for Inhibrx Biosciences Inc.2025 Earnings Surprises & Verified Technical Trade Signals - newser.com
Inhibrx Biosciences (NASDAQ:INBX) Given Sell (D) Rating at Weiss Ratings - MarketBeat
Custom watchlist performance reports with Inhibrx Biosciences Inc.Earnings Trend Report & Long-Term Growth Portfolio Plans - newser.com
What drives Inhibrx Biosciences Inc stock priceValue Stock Picks & Minimal Investment Trading Plans - earlytimes.in
Technical signs of recovery in Inhibrx Biosciences Inc.Quarterly Investment Review & High Conviction Investment Ideas - newser.com
What analysts say about Inhibrx Biosciences Inc stockVolatility Index Analysis & Achieve Consistent Profits - earlytimes.in
Leading vs lagging indicators on Inhibrx Biosciences Inc. performanceForecast Cut & AI Enhanced Trade Execution Alerts - newser.com
Inhibrx Biosciences Inc. stock retracement – recovery analysisGap Down & Long-Term Safe Investment Plans - newser.com
What technical models suggest about Inhibrx Biosciences Inc.’s comeback2025 Macro Impact & Short-Term High Return Strategies - newser.com
Inhibrx Biosciences (NASDAQ:INBX) Hits New 52-Week HighWhat's Next? - MarketBeat
Inhibrx Biosciences Inc Azioni (INBX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Inhibrx Biosciences Inc Azioni (INBX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Kayyem Jon Faiz | Director |
Nov 19 '24 |
Buy |
14.23 |
69,686 |
991,416 |
51,093 |
| Kayyem Jon Faiz | Director |
Nov 20 '24 |
Buy |
14.19 |
37,500 |
532,204 |
69,843 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):